Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia-Reference-Cited by-同舟云学术

Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia

Published:2016-02-25 Issue:2 Volume:173 Page:265-273
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

López Cristina¹,Bergmann Anke K.¹²,Paul Ulrike¹,Murga Penas Eva M.¹,Nagel Inga¹,Betts Matthew J.³,Johansson Patricia⁴⁵,Ritgen Matthias⁶,Baumann Tycho⁷,Aymerich Marta⁸,Jayne Sandrine⁹,Russell Robert B.³,Campo Elias⁸,Dyer Martin JS⁹,Dürig Jan⁴¹⁰,Siebert Reiner¹

Affiliation:

1. Institute for Human Genetics; Christian-Albrechts-University Kiel & University Hospital Schleswig Holstein; Kiel Germany

2. Department of Paediatrics; Christian-Albrechts-University Kiel & University Hospital Schleswig Holstein; Kiel Germany

3. Cell Networks; Bioquant; University of Heidelberg; Heidelberg Germany

4. Department of Haematology; University Hospital Essen; University of Duisburg-Essen; Essen Germany

5. Faculty of Medicine; Institute of Cell Biology (Cancer Research); University of Duisburg-Essen; Essen Germany

6. Second Department of Medicine; University Hospital of Schleswig-Holstein; Kiel Germany

7. Department of Haematology; Hospital Clínic; Institut d′Investigaciones Biomèdiques August Pi I Sunyer (IDIBAPS); Barcelona Spain

8. Haematopathology Unit; Hospital Clínic; Institut d′Investigaciones Biomèdiques August Pi I Sunyer (IDIBAPS); University of Barcelona; Barcelona Spain

9. Ernest and Helen Scott Haematological Research Institute; University of Leicester; Leicester UK

10. German Cancer Consortium (DKTK); Heidelberg Germany

Funder

Seventh Framework Programme

German Cancer Consortium

Leicester Experimental Cancer Medicine Centre

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.13952/fullpdf

Reference57 articles.

1. Predicting functional effect of human missense mutations using PolyPhen-2;Adzhubei;Current Protocols in Human Genetics,2013

2. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia;Bains;Leukemia,2012

3. The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse;Bandapalli;Haematologica,2014

4. Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia;Bellanger;Leukemia,2014

5. Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia;Bergmann;Genes Chromosomes Cancer,2014

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family–negative T-prolymphocytic leukemia;American Journal of Clinical Pathology;2024-06-30

2. A Novel JAK2 Fusion in T‐Cell Prolymphocytic Leukemia;Genes, Chromosomes and Cancer;2024-06

3. Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency;International Journal of Molecular Sciences;2024-03-04

4. Prolymphocytic Leukaemia: an Update on Biology and Treatment;Current Oncology Reports;2024-01-02

5. Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH);Current Research in Translational Medicine;2023-10